Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11726
Aware
AWRE
$26.8M
| $72.6K | ﹤0.01% |
45,939
+12,449
| +37% | +$20.1K |
|
11727
PUT
Health Catalyst
HCAT
$120M
| $72.5K | ﹤0.01% |
16,000
+700
| +5% | +$3.7K |
|
11728
Tenaya Therapeutics
TNYA
$156M
| $72.4K | ﹤0.01% |
126,960
-19,802
| -13% | -$19.5K |
|
11729
CALL
Inogen
INGN
$146M
| $72K | ﹤0.01% |
10,100
-67,600
| -87% | -$638K |
|
11730
CALL
Real REMAX Group Inc. Common Stock
REAX
$515M
| $71.9K | ﹤0.01% |
1,770
-200
| -10% | -$9.49K |
|
11731
Noble Corporation PLC Tranche 2 Warrants
NE.WS.A
| $71.6K | ﹤0.01% |
+11,601
| New | +$110K |
|
11732
PUT
Stereotaxis
STXS
$147M
| $71.5K | ﹤0.01% |
+40,600
| New | +$86.5K |
|
11733
PUT
Pulmonx
LUNG
$104M
| $71.3K | ﹤0.01% |
10,600
-300
| -3% | -$2.12K |
|
|
NOVA
11734
CALL
DELISTED
Sunnova Energy
NOVA
| $71.2K | ﹤0.01% |
192,400
-505,700
| -72% | -$973K |
|
11735
Cineverse
CNVS
$57.5M
| $70.9K | ﹤0.01% |
+22,443
| New | +$84.1K |
|
11736
PUT
TETRA Technologies
TTI
$1.03B
| $70.9K | ﹤0.01% |
21,100
-252,400
| -92% | -$1.01M |
|
|
THRD
11737
CALL
DELISTED
Third Harmonic Bio
THRD
| $70.4K | ﹤0.01% |
+20,300
| New | +$98.4K |
|
11738
CALL
Quanterix
QTRX
$125M
| $70.3K | ﹤0.01% |
10,800
-22,000
| -67% | -$184K |
|
|
JBIO
11739
CALL
Jade Biosciences
JBIO
$1.35B
| $70.3K | ﹤0.01% |
800
-1,149
| -59% | -$101K |
|
11740
PUT
ZipRecruiter
ZIP
$353M
| $70.1K | ﹤0.01% |
+11,900
| New | +$79.3K |
|
11741
PUT
Resources Connection
RGP
$147M
| $70K | ﹤0.01% |
10,700
-1,100
| -9% | -$8.54K |
|
11742
PUT
JELD-WEN Holding
JELD
$189M
| $69.8K | ﹤0.01% |
+11,700
| New | +$86.9K |
|
11743
PUT
Upland Software
UPLD
$13.7M
| $69.8K | ﹤0.01% |
2,440
-430
| -15% | -$16.3K |
|
|
ASRT
11744
PUT
DELISTED
Assertio
ASRT
| $69.7K | ﹤0.01% |
6,933
+5,486
| +379% | +$65.4K |
|
11745
Jasper Therapeutics
JSPR
$23.3M
| $69.2K | ﹤0.01% |
16,091
-6,723
| -29% | -$44.7K |
|
11746
Satellogic
SATL
$816M
| $69K | ﹤0.01% |
19,332
+1,353
| +8% | +$4.55K |
|
11747
Immatics
IMTX
$1.28B
| $69K | ﹤0.01% |
15,291
-6,294
| -29% | -$32.8K |
|
|
KG
11748
Kestrel Group
KG
$59.3M
| $68.8K | ﹤0.01% |
6,036
+3,057
| +103% | +$57.6K |
|
11749
CALL
Future Fuel
FF
$228M
| $68.3K | ﹤0.01% |
17,500
+5,800
| +50% | +$27.9K |
|
11750
PUT
GoPro
GPRO
$112M
| $68.1K | ﹤0.01% |
103,200
-51,200
| -33% | -$45.2K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.